Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: J Psychopathol Clin Sci. 2021 Dec 23;131(1):14–25. doi: 10.1037/abn0000721

Table 2.

Inferential statistics for the association between different measures of pubertal timing and internalizing psychopathology.

Prospective Cross-sectional Combined
Median point estimate [CI] Share of results in negative direction Share of sign. results in negative direction Median point estimate [CI] Share of results in negative direction Share of sign. results in negative direction Median point estimate [CI] Share of results in negative direction Share of sign. results in negative direction
observed p share p share p observed p share p share p observed p share p share p
Residualized self-report PDS stage −0.14 [−0.17; −0.07] <.001 91/112 <.001 8 .650 −0.08 [−0.13; −0.06] <.001 100/112 <.001 1 1 −0.10 [−0.13; −0.08] <.001 191/224 <.001 9 .998
Residualized parent-report PDS stage −0.18 [−0.24; −0.13] <.001 96/112 <.001 14 .012 −0.09 [−0.12; −0.05] <.001 95/112 <.001 0 1 −0.13 [−0.16; −0.09] <.001 191/224 <.001 14 .752
Residualized LD Tanner stage −0.29 [−0.35; −0.22] <.001 112/112 <.001 38 <.001 −0.31 [−0.33; −0.22] <.001 112/112 <.001 39 <.001 −0.30 [−0.32; −0.23] <.001 224/224 <.001 77 <.001
Residualized gonadal composite −0.20 [−0.26; −0.16] <.001 111/112 <.001 36 <.001 −0.15 [−0.21; −0.11] <.001 99/112 <.001 16 <.001 −0.18 [−0.22; −0.15] <.001 210/224 <.001 52 <.001
Residualized adrenal composite −0.19 [−0.21; −0.11] <.001 100/112 <.001 17 .001 −0.19 [−0.20; −0.13] <.001 112/112 <.001 4 .997 −0.19 [−0.19; −0.13] <.001 212/224 <.001 21 .057
Self-report subjective timing 0.04 [−0.03; 0.05] .009 64/112 .156 4 .997 −0.17 [−0.19; −0.11] <.001 112/112 <.001 13 .063 −0.08 [−0.11; −0.05] <.001 160/224 <.001 17 .529
Parent-report subjective timing −0.14 [−0.17; −0.09] <.001 80/112 <.001 3 .999 −0.19 [−0.17; −0.09] <.001 99/112 <.001 0 1 −0.16 [−0.16; −0.10] <.001 179/224 <.001 3 1
Age at menarche NA NA NA NA NA NA −0.05 [−0.05; 0.01] .055 66/112 .088 0 1
Residualized DHEA −0.15 [−0.13; −.05] <.001 94/112 <.001 0 1 −0.04 [−0.08; 0] .001 82/112 <.001 0 1 −0.08 [−0.09; −0.03] <.001 176/224 <.001 0 1
Residualized testosterone −0.03 [−0.03; 0.05] .058 69/112 .018 0 1 −0.03 [−0.06; 0.01] .060 80/112 <.001 0 1 −0.03 [−0.04; 0.01] .012 149/224 <.001 0 1
Residualized estradiol 0.11 [0.08; 0.15] <.001 6/112 1 0 1 −0.01 [−0.05; 0.02] .371 63/112 .221 0 1 0.05 [0.03; 0.09] <.001 69/224 1 0 1
All predictors combined −0.10 [−0.11;−0.08] <.001 807/1120 <.001 120 <.001 −0.10 [−0.12;−0.10] <.001 954/1120 <.001 73 .594 −0.10 [−0.11;−0.09] <.001 1827/2352 <.001 193 <.001

Note: “Prospective ” statistics are from models of Time 1 pubertal timing and Time 2 outcomes, “cross-sectional” from models of Time 2 pubertal timing and outcomes, and “combined” from all of those models. Statistics are based on bootstrapped null models, see Methods for details. DHEA=dehydroepiandrosterone, CI=confidence interval, LD=Line Drawings, PDS=Pubertal Development Scale.